Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at SEK 200.7B, ahead of Merck & Co (SEK 148.3B) and Novartis (SEK 116.4B). Figures as of 19 Nov 2026, 04:44 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSEK 200.7B
- Median
- SEK 5.8B
- Combined market value
- SEK 51.51T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SEK 200.7B | SEK 6.68T | SEK 2,776.70 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | SEK 148.3B | SEK 3.46T | SEK 1,402.91 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | SEK 116.4B | SEK 2.98T | SEK 1,580.39 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | SEK 104B | SEK 1.24T | SEK 606.45 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SEK 86.8B | SEK 1.84T | SEK 1,063.84 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | SEK 86.5B | SEK 1.15T | SEK 479.79 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | SEK 74B | SEK 12.54T | SEK 14,079.49 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | SEK 58.2B | SEK 2.82T | SEK 1,820.18 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | SEK 53.2B | SEK 5.15T | SEK 2,912.22 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | SEK 51.8B | SEK 1.38T | SEK 5,462.26 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | SEK 46.3B | SEK 469.4B | SEK 4,109.55 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | SEK 45.9B | SEK 991.5B | SEK 494.65 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | SEK 40B | SEK 1.77T | SEK 401.49 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | SEK 37.9B | SEK 691.9B | SEK 216.58 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 36.2B | SEK 501.7B | SEK 430.00 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | SEK 31.7B | SEK 996B | SEK 9,627.61 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | SEK 23.5B | SEK 354B | SEK 871.29 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | SEK 17.5B | SEK 320B | SEK 518.99 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | SEK 16.9B | SEK 203.7B | SEK 1,521.23 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | SEK 15.9B | SEK 250.4B | SEK 5,878.61 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | SEK 14.5B | SEK 285.7B | SEK 394.36 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 14.2B | SEK 161.9B | SEK 2,522.85 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | SEK 13.5B | SEK 236.7B | SEK 206.50 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SEK 13.4B | SEK 121.2B | SEK 625.50 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | SEK 11.6B | SEK 1.63T | SEK 285.71 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | SEK 10B | SEK 51.2B | SEK 613.28 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | SEK 9.3B | SEK 58.7B | SEK 86.24 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | SEK 9.2B | SEK 32.1B | SEK 165.46 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | SEK 7B | SEK 180.6B | SEK 2,752.56 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | SEK 6.3B | SEK 402B | SEK 699.21 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | SEK 5.8B | SEK 74.7B | SEK 853.58 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | SEK 5.8B | SEK 154.7B | SEK 794.32 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | SEK 5.5B | SEK 135.9B | SEK 271.87 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | SEK 5.2B | SEK 267.6B | SEK 1,219.83 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | SEK 4B | SEK 80.2B | SEK 477.04 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | SEK 3.8B | SEK 46.4B | SEK 278.89 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | SEK 3.6B | SEK 86.9B | SEK 3,107.52 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | SEK 3.6B | SEK 64.6B | SEK 1,590.77 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SEK 3.3B | SEK 71.8B | SEK 1,364.42 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | SEK 3.2B | SEK 49.3B | SEK 283.17 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | SEK 3B | SEK 61.5B | SEK 941.76 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | SEK 2.9B | SEK 77.6B | SEK 222.79 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | SEK 2.6B | SEK 40.6B | SEK 296.51 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 2.3B | SEK 62.1B | SEK 438.96 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | SEK 2.3B | SEK 85.5B | SEK 106.91 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 2B | SEK 94.2B | SEK 4,053.35 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | SEK 1.8B | SEK 60.8B | SEK 3,041.54 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 1.7B | SEK 76B | SEK 967.82 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 1.7B | SEK 127.2B | SEK 152.53 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | SEK 1.3B | SEK 84.5B | SEK 1,294.77 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | SEK 1.2B | SEK 72.8B | SEK 522.55 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | SEK 1.2B | SEK 75.5B | SEK 690.25 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SEK 947.3M | SEK 49.1B | SEK 511.56 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SEK 872.8M | SEK 98.1B | SEK 1,033.09 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | SEK 805.9M | SEK 101.8B | SEK 673.25 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | SEK 751.5M | SEK 49.2B | SEK 140.11 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | SEK 622.6M | SEK 46.1B | SEK 421.24 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 552.9M | SEK 84B | SEK 1,212.09 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | SEK 520.2M | SEK 48.2B | SEK 855.10 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | SEK 477.9M | SEK 66.1B | SEK 974.85 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | SEK 221.6M | SEK 53.6B | SEK 1,271.35 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1822 SEK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (SEK 200.7B), Merck & Co (SEK 148.3B) and Novartis (SEK 116.4B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 04:44 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of SEK 51.51T as of 19 Nov 2026, 04:44 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.